SHENYANG, China, Feb. 11 /PRNewswire-FirstCall/ -- 3SBio Inc. , a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the fourth quarter and full year ended December 31, 2007 after the US market closes on Wednesday, February 20, 2008.
The earnings release will be available on the investor relations page of its website at http://www.3sbio.com/en/News/ShowInfo_nnn11.aspx?ID=71.
Following the earnings announcement, 3SBio Inc. senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 9:00 pm (Beijing/Hong Kong) on Thursday, February 21, 2008 to discuss its 2007 fourth quarter and full year financial results and recent business activity. The conference call may be accessed by calling (US) +1 480 629 9041/ (UK) + 44 20 8515 2301/ (HK) + 852 3009-5027. A telephone replay will be available shortly after the call until March 6, 2008 at (US) +1 303 590 3030/ (UK) + 44 207 154 2833, Passcode: 3839328; and (HK) + 852 2287 4304, Passcode: 104110#
A live webcast of the conference call and replay will be available on the investor relations page of 3SBio’s website at http://www.3sbio.com/en/News/ShowInfo_nnn11.aspx?ID=71.
About 3SBio Inc.
www.3sbio.com
CONTACT: Investors, Kevin Teo, CFO, 3SBio Inc., +86 24 2581 1820, or
Mahmoud Siddig, +1-212-889-4350, or Ruby Yim, +852 3196 3712, both of
Taylor Rafferty, for 3SBio Inc., or Media, John Dooley of Taylor Rafferty,
+1-212-889-4350, for 3SBio Inc.
Web site: http://www.3sbio.com/
http://www.3sbio.com/en/News/ShowInfo_nnn11.aspx?ID=71/
